Clinical trial
Predicting Response to Neoadjuvant Endocrine Therapy (Neo-PREDICT)
NCT06806930
Study timeline
Study start (actual)2024-10-01Date precision: day
Registry last updated2026-03-03
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Breast Cancer Stage Iunresolved
Breast Cancer Stage IIunresolved
Breast Cancer Stage IIIunresolved
Carcinoma, Breastunresolved
Interventions
Sponsors & collaborators
George Washington Universitylead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06806930 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.